Besides, survival analysis indicated that S100A16 expression of PAAD patients was negatively associated with OS time (HR = 2.3, P=5.6E − 05, Figure 5(i)) and DFS time (HR = 2.6, P=3E − 05, Figure 5(j)), significantly. Here, S100A16 is linked to pancreatic adenocarcinoma.